401 related articles for article (PubMed ID: 12601486)
21. Scintigraphy using (99m)Tc-MIBI (sestamibi), a sensitive parameter of activity of multiple myeloma.
Bacovsky J; Scudla V; Myslivecek M; Nekula J; Vytrasová M
Neoplasma; 2005; 52(4):302-6. PubMed ID: 16059646
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Tc-99m sestamibi and TI-201 uptake in multiple myeloma.
Chun KA; Cho IH; Won KC; Lee KH; Lee HW; Hyun MS; Hayashida K
Clin Nucl Med; 2001 Mar; 26(3):212-5. PubMed ID: 11245112
[TBL] [Abstract][Full Text] [Related]
23. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
[TBL] [Abstract][Full Text] [Related]
24. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
[TBL] [Abstract][Full Text] [Related]
25. Correlation between 99mTc-MIBI uptake and angiogenesis in MIBI-positive breast lesions.
Bekiş R; Degirmenci B; Aydin A; Ozdogan O; Canda T; Durak H
Nucl Med Biol; 2005 Jul; 32(5):465-72. PubMed ID: 15982577
[TBL] [Abstract][Full Text] [Related]
26. Flow cytometric detection of aneuploid CD38(++) plasmacells and CD19(+) B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients.
Santonocito AM; Consoli U; Bagnato S; Milone G; Palumbo GA; Di Raimondo F; Stagno F; Guglielmo P; Giustolisi R
Leuk Res; 2004 May; 28(5):469-77. PubMed ID: 15068900
[TBL] [Abstract][Full Text] [Related]
27. Distribution of myeloma plasma cells in peripheral blood and bone marrow correlates with CD56 expression.
Rawstron A; Barrans S; Blythe D; Davies F; English A; Pratt G; Child A; Morgan G; Jack A
Br J Haematol; 1999 Jan; 104(1):138-43. PubMed ID: 10027726
[TBL] [Abstract][Full Text] [Related]
28. CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells.
Kim D; Park CY; Medeiros BC; Weissman IL
Leukemia; 2012 Dec; 26(12):2530-7. PubMed ID: 22733078
[TBL] [Abstract][Full Text] [Related]
29. Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma.
Blocklet D; Schoutens A; Kentos A; Feremans W
Eur J Nucl Med; 2001 Sep; 28(9):1430-2. PubMed ID: 11585304
[No Abstract] [Full Text] [Related]
30. Tc-99m MIBI localization in bone marrow: a marker of bone marrow malignancy.
Wakasugi S; Teshima H; Nakamura H; Hashizume T; Maeda T; Hiraoka A; Hasegawa Y; Masaoka T
Clin Nucl Med; 1998 Oct; 23(10):664-71. PubMed ID: 9790040
[TBL] [Abstract][Full Text] [Related]
31. An approach for diagnosing plasma cell myeloma by three-color flow cytometry based on kappa/lambda ratios of CD38-gated CD138(+) cells.
Nakayama S; Yokote T; Hirata Y; Iwaki K; Akioka T; Miyoshi T; Takayama A; Nishiwaki U; Masuda Y; Ikemoto T; Tanaka H; Nishimura Y; Tsuji M; Hanafusa T
Diagn Pathol; 2012 Sep; 7():131. PubMed ID: 23021410
[TBL] [Abstract][Full Text] [Related]
32. Extranodal marginal zone B cell lymphomas of the uvea: an analysis of 13 cases.
Coupland SE; Foss HD; Hidayat AA; Cockerham GC; Hummel M; Stein H
J Pathol; 2002 Jul; 197(3):333-40. PubMed ID: 12115879
[TBL] [Abstract][Full Text] [Related]
33. [Expression and clinical significance of Notch1 on the membrane of bone marrow CD38(+)CD138(+) plasma cells in the patients with multiple myeloma].
Zhao YR; Fu R; Guan J; Gao S; Liu H; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Wu YH; Song J; Wang HQ; Xing LM; Wang J; Li LJ; Shao ZH
Zhonghua Xue Ye Xue Za Zhi; 2012 Apr; 33(4):274-7. PubMed ID: 22781716
[TBL] [Abstract][Full Text] [Related]
34. Predictive value of technetium-99m sestamibi in patients with multiple myeloma and potential role in the follow-up.
Pace L; Catalano L; Del Vecchio S; Di Gennaro F; De Renzo A; Sica G; Califano C; Tedesco N; Borrelli G; Rotoli B; Salvatore M
Eur J Nucl Med; 2001 Mar; 28(3):304-12. PubMed ID: 11315597
[TBL] [Abstract][Full Text] [Related]
35. Relation between S-phase fraction of myeloma cells and anemia in patients with multiple myeloma.
Fosså A; Brandhorst D; Myklebust JH; Seeber S; Nowrousian MR
Exp Hematol; 1999 Nov; 27(11):1621-6. PubMed ID: 10560909
[TBL] [Abstract][Full Text] [Related]
36. Plasmacellular differentiation in extranodal marginal zone B cell lymphomas of the ocular adnexa: an analysis of the neoplastic plasma cell phenotype and its prognostic significance in 136 cases.
Coupland SE; Hellmich M; Auw-Haedrich C; Lee WR; Anagnostopoulos I; Stein H
Br J Ophthalmol; 2005 Mar; 89(3):352-9. PubMed ID: 15722318
[TBL] [Abstract][Full Text] [Related]
37. A comparison of fluorine-18 fluoro-deoxyglucose PET and technetium-99m sestamibi in assessing patients with multiple myeloma.
Mileshkin L; Blum R; Seymour JF; Patrikeos A; Hicks RJ; Prince HM
Eur J Haematol; 2004 Jan; 72(1):32-7. PubMed ID: 14962260
[TBL] [Abstract][Full Text] [Related]
38. Potential of (99m)Tc-MIBI for detecting bone marrow metastases.
Wakasugi S; Noguti A; Katuda T; Hashizume T; Hasegawa Y
J Nucl Med; 2002 May; 43(5):596-602. PubMed ID: 11994520
[TBL] [Abstract][Full Text] [Related]
39. Relation between Tc-99m sestamibi uptake and biological factors in hyperparathyroidism.
Cermik TF; Puyan FO; Sezer A; Firat MF; Berkarda S
Ann Nucl Med; 2005 Jul; 19(5):387-92. PubMed ID: 16164195
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of early 99mTc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma.
Del Vecchio S; Zannetti A; Aloj L; Caracò C; Ciarmiello A; Salvatore M
Eur J Nucl Med Mol Imaging; 2003 Jun; 30(6):879-87. PubMed ID: 12721767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
